Prior to prescribing valproate, what must have been demonstrated regarding alternative therapies?

Prior to prescribing valproate, what must have been demonstrated regarding alternative therapies?

• A. They are more expensive
• B. They were effective
• C. They were considered and found ineffective or poorly tolerated
• D. They were approved by a specialist

Answer: (C)

The main idea is that valproate is reserved for when safer, alternative treatments have been tried and shown not to work well or to cause unacceptable side effects. This stepwise approach helps minimize exposure to valproate’s risks, especially its teratogenic potential and other adverse effects. If other therapies have been tested and were ineffective or poorly tolerated, using valproate becomes a justified option. It isn’t about cost or needing specialist approval—those aren’t the gating factors; the key is demonstrating that alternatives were explored and found lacking in efficacy or tolerability.

The main idea is that valproate is reserved for when safer, alternative treatments have been tried and shown not to work well or to cause unacceptable side effects. This stepwise approach helps minimize exposure to valproate’s risks, especially its teratogenic potential and other adverse effects. If other therapies have been tested and were ineffective or poorly tolerated, using valproate becomes a justified option. It isn’t about cost or needing specialist approval—those aren’t the gating factors; the key is demonstrating that alternatives were explored and found lacking in efficacy or tolerability.